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Explains Misunderstanding Both
Leonard Hayflick
C
ommunication in the ﬁeld of
biogerontology is a mineﬁeld
because all of the commonly
used terms have no universally
accepted deﬁnitions. In a series of ﬁve
annual meetings that I chaired recently
in an attempt to deﬁne common terms,
the dozen or more experts who
attended could not agree on the
deﬁnition of almost all of them,
including ‘‘aging.’’ The committee was
disbanded and the communications
dilemma remains.
‘‘Aging, Bench to Bedside,’’ the
collection of mini reviews published as
a series in this journal, is representative
of this unsolved problem. Not only
does the problem result in
communication failures, it also
produces erroneous interpretations of
research results; illogical allocation of
research funds; and misdirected
scientiﬁc, economic, social, and
political policy decisions [1–3]. There is
no other ﬁeld of science in which a
similarly bleak situation exists.
As a consequence of the terminology
dilemma, I will deﬁne for use in this
editorial the four aspects of the
ﬁnitude of life: aging, the determinants
of longevity, age-associated diseases,
and death. I will not discuss the latter,
although even this word deﬁes a
universally accepted deﬁnition.
The Aging Process
Age changes can occur in only two
fundamental ways: by a purposeful
program driven by genes or by random,
accidental events.
It is a cornerstone of modern biology
that a purposeful genetic program
drives all biological processes that
occur from the beginning of life to
reproductive maturation. However,
once reproductive maturation is
reached, thought is divided with
respect to whether the emerging aging
process is a continuation of the genetic
program or whether it is the result of
the accumulation of random,
irreparable losses in molecular ﬁdelity.
The deterministic dream of 19th
century physicists was torpedoed in the
20th century with Heisenberg’s
discovery of the uncertainty principle.
In fact, the fundamental laws of physics
can only be expressed as probabilities.
The most compelling evidence for the
belief that biological aging is also a
random process is that everything in
the universe changes or ages in space-
time without being driven by a
purposeful program. Although there is
no direct evidence that genes drive age
changes, their critical role in longevity
determination is indisputable.
There is a huge body of knowledge
supporting the belief that age changes
are characterized by increasing
entropy, which results in the random
loss of molecular ﬁdelity, and
accumulates to slowly overwhelm
maintenance systems [1–4].
Both biological systems and
inanimate objects incur change over
time. Living systems, however, are,
among other properties,
distinguishable from inanimate objects,
because a purposeful genetic program
governs the changes that occur from
their beginning until reproductive
maturation. In inanimate objects,
change is not programmed. It is
continuous and never ending. Whether
the changes that occur in inanimate
objects are called age changes or not
occurs because of the tendency for
humans to view the physical world in
anthropomorphic terms.
The common denominator that
underlies all modern theories of
biological aging is change in molecular
structure and, hence, function. These
changes are the result of entropic
changes, which is now supported by the
recent reinterpretation of the Second
Law of Thermodynamics, where the
belief that it only applies to closed
systems has been overturned [5].
Entropy is the tendency for
concentrated energy to disperse when
unhindered regardless of whether the
system is open or closed. The
hindrance of entropic change is the
relative strength of chemical bonds.
The prevention of chemical bond
breakage, among other structural
changes, is absolutely essential for life.
Through evolution, natural selection
has favored energy states capable of
maintaining ﬁdelity in most molecules
until reproductive maturation, after
which there is no species survival value
for those energy states to be
maintained indeﬁnitely.
The dispersal of energy may result in
a biologically inactive or
malfunctioning molecule. Energy
dispersal is never entirely eliminated
but it can be circumvented for varying
time periods by repair or replacement
processes. The internal presence of
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represents a major difference between
living and inanimate forms.
From the standpoint of a physicist, a
lowered energy state is not necessarily
disorder, because it simply results in
the identical molecule with a lowered
energy state. The fact that such a
molecule might be biologically inactive
may not concern the physicist, but it
deﬁnitely does concern the biologist
and, especially, the biogerontologist.
The aging process occurs because the
changed energy states of biomolecules
renders them inactive or
malfunctioning. Identical events also
occur before the aging phenotype
appears, but repair and replacement
processes are capable of maintaining
the balance in favor of functioning
molecules; otherwise, the species would
vanish. After reproductive maturation,
this balance slowly shifts to one in
which molecules that lose their
biologically active energy states are less
likely to be replaced or repaired. The
diminution of repair and replacement
capability is further exacerbated,
because the enormously complex
biomolecules that compose the repair
and replacement systems also suffer the
same fate as their substrate
biomolecules.
When the escalating loss of molecular
ﬁdelity ultimately exceeds repair and
turnover capacity, vulnerability to
pathology or age-associated diseases
increases [1,3,6]. Immortal biological
systems cannot exist, if for no other
reason than molecular turnover (or
dilution) insures that the molecules
present at the beginning of a biological
lineageare unlikelytobe present inthat
lineage when it reaches Avogadro’s
Numberofabout6310
23cells.Theonly
biological property that is long lasting
on an evolutionary time scale is the
message coded in information-
containing molecules, but even that
dataissubjecttomutationorchange[7].
Although the loss of molecular
ﬁdelity is a random process, there is,
nonetheless, a strong element of
uniformity, in that errors will occur
ﬁrst in the same families of the most
vulnerable molecules in similar cells,
organs, or objects. The components of
a system in which these molecules are a
part then become the weakest link in
that system. This accounts for the
similarity in the aging phenotype as it
progresses within species members.
Similar events occur in aging
inanimate objects where, for example,
automobiles of a particular make,
model, and year of manufacture may
have a greater probability of failure in
a common weakest link, such as the
electrical system. In another car of
similar manufacture but different
make, year, or model, molecules in the
cooling or exhaust system will suffer
age changes fastest and become the
most probable system to fail ﬁrst. There
is, inevitably, a weakest link with the
probability of failing ﬁrst in a similar
component of all complex entities. This
‘‘mean time to failure’’ for a cheap car
might be six or seven years, and for
newborns today in developed countries
their mean time to failure is in the
range of 75–85 years.
In humans in developed countries,
the weakest links are the cells that
compose the vascular system and those
in which cancer is most probable. The
molecular instability, or aging process,
that occurs in these cells is the weakest
link that increases vulnerability to
these two leading causes of death. This
is why knowing how fundamental age
changes occur could lead to a better
understanding of the etiology of all of
the leading causes of death.
The ‘‘hypothesis that aging is due in
part to mtDNA damage and associated
mutations...[because the
mitochondrion] generates most cellular
ROS’’ [8] is an excellent example of one
of the many possible active causes of
the loss of molecular ﬁdelity that
characterizes the aging process. Both
active and spontaneous entropic
processes described above must be
balanced by repair and turnover to
insure species survival until
reproductive success.
Recent studies done using bacteria
seem to support the thesis, described
above, that ‘‘damaged proteins’’ are the
cause of age changes. When a
bacterium like Escherichia coli divides by
ﬁssion, one of the two daughter
lineages is ‘‘damaged enriched’’ and the
other has ‘‘low damage’’ [9]. The former
are ‘‘non-culturable or genetically
dead’’ while the latter are
‘‘reproductively competent.’’ In
Caulobacter crescentus, replicative
senescence has been observed [10], a
phenomenon that we ﬁrst described in
normal human cells more than 45 years
ago [11]. The phenomenon has also
been reported to occur in E. coli and in
Saccharomyces cerevisae [12]. The
occurrence of replicative senescence in
normal cells appears to be a universal
biological phenomenon.
The Determinants of Longevity
The second aspect of the ﬁnitude of
life is longevity determination—a
process that is completely different
from aging.
Unlike aging, the genome governs
the processes that determine longevity.
These are the systems that synthesize
molecules and repair or replace them.
When the repair or replacement
systems are unable to maintain the
positive balance that existed prior to
reproductive success, a tipping point is
reached where the aging phenotype
slowly becomes manifest.
Aging must occur in molecules that
previously existed with no age changes.
It is this prior functional state of
molecules and the subsequent
efﬁciency of their maintenance that
governs longevity determination.
Unlike the stochastic process that
characterizes aging, longevity
determination is not a random process.
It is governed by the level of
physiological reserve reached at the
time of reproductive maturation that,
through natural selection, was achieved
to better guarantee survival to that age.
The determination of longevity is
incidental to the main goal of the
genome, which is to govern events until
reproductive maturity occurs. Thus,
the genome only indirectly governs
longevity.
The variations in excess
physiological capacity, repair, and
turnover account for the differences
found in longevity both within and
among species. One might think of
longevity determination as the energy
state of molecules before they incur age
changes, and aging as the state of
molecules after energy dissipation
results in an irreparable state of
functional loss. Longevity
determination is a genome-driven
anabolic process that addresses the
question: ‘‘Why do we live as long as we
do?’’ Aging is a chance-driven catabolic
process that addresses the question:
‘‘Why do things ﬁnally go wrong?’’
Studies on ‘‘dietary restriction’’ (DR)
[13–15] would be better interpreted to
have contributed to our understanding
of longevity determination than to our
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longevity found by DR does not
provide proof that it directly affects the
aging process, because longevity is
commonly used as the endpoint in
these studies, and not age changes.
Increased longevity also could occur
if DR eliminated or delayed the
appearance of pathology, because
biomarkers for aging in most animals
are either unknown or not evaluated.
Furthermore, because controls are
either fed ad lib, or some arbitrary
number of calories, it would be just as
logical to conclude that overfed
animals have a reduced longevity as it
would to conclude that DR increases
longevity. Indeed, alternating periods
of feast and famine is the usual lifestyle
for most animals and this is much more
likely to mimic the effects of DR.
Indeed, DR research might be telling us
more about the actual longevity of feral
animals absent causes of death
attributable to predation, disease, or
accidents.
The many studies on gene mutations
in C. elegans, drosophila, and other
invertebrates [13–15] that have led to
the view that genes are involved in
aging have not demonstrated that gene
manipulation has slowed, stopped, or
reversed biomarkers of aging. When
all-cause mortality is used as the end
point, as is done in experiments with
these animals, it cannot be assumed
that age changes are being affected.
These studies are more accurately
interpreted to have an impact on our
understanding of longevity
determination.
Furthermore, genes that govern the
aging process are unnecessary for it to
occur. Just as blueprints are vital to
construct a complex machine, but
contain no information describing a
system to cause its aging, the genome is
necessary to govern biological
development and maintenance, but it
contains no instructions to cause the
animal to age. Automobiles know how
to age without requiring instructions.
Both ultimately fail because of changes
in molecular ﬁdelity driven by
increasing entropy.
In unicellular organisms like yeast,
aging has been deﬁned either as the
length of time that a yeast cell can
survive in a nondividing state, or by the
number of daughter cells produced by
a mother cell before senescence [13]. In
higher animals, chronological time is
generally recognized as a poor measure
of the rate of aging because of the
enormous variations in the aging
phenotype among individuals. And, the
number of progeny produced before
senescence occurs has never been
considered to be related to aging. It is
more likely that what is being studied
are longevity determinants for reasons
already given. It has been known for
more than a century that longevity
determinants in invertebrates are,
unlike aging, capable of manipulation.
Age-Associated Diseases
The third aspect of the ﬁnitude of
life is age-associated disease. The
distinction between the aging process
and age-associated disease is not only
based on the deﬁnition of aging
described above, but it is also rooted in
several practical observations.
Unlike any disease, age changes:
(1) Occur in every multicellular
animal that reaches a ﬁxed size at
reproductive maturity.
(2) Cross virtually all species barriers.
(3) Occur in all members of a species
only after the age of reproductive
maturation.
(4) Occur in all animals removed
from the wild and protected by humans
even when that species probably has
not experienced aging for thousands or
even millions of years.
(5) Occur in virtually all animate and
inanimate matter.
(6) Have the same universal
molecular etiology, that is,
thermodynamic instability.
Unlike aging, there is no disease or
pathology that shares these six
qualities.
The inexorable loss of molecular
ﬁdelity that deﬁnes aging can either
lead to changes that may be
nonpathological affronts to vanity,
inconveniences, or simply
uncomfortable. When the same kind of
molecular mischief occurs in the cells
of vital organs, leading to an increase in
vulnerability to disease or pathology,
treatment is required because life may
be threatened.
The fundamental aging process is not
a disease but it increases vulnerability
to disease. Because this critical
distinction is generally unappreciated,
there is a continuing belief that the
resolution of age-associated diseases
will advance our understanding of the
fundamental aging process [16]. It will
not. This is analogous to believing that
the successful resolution of childhood
pathologies, such as poliomyelitis,
Wilms’ tumors, and iron deﬁciency
anemia advanced our understanding of
childhood development. It did not.
It is often observed that, ‘‘The
classical evolutionary biological theory
of aging tells us that senescence occurs
in age-structured populations because
of the decline in the force of natural
selection with age’’ [17]. And, a less
common belief that, ‘‘...the force of
natural selection could conceivably
increase with age’’ [17]. These beliefs
belie the fact that the forces of natural
selection are constant and that large
changes usually occur only on an
evolutionary time scale. What changes
with age is an animal’s ability to adapt
to the constant forces of natural
selection.
The failure to distinguish the
fundamental biology of aging
(biogerontology) from age-associated
pathology (geriatric medicine), and
both from longevity determinants, is
the most serious impediment to our
understanding of the aging process.
This failure is exempliﬁed best by
realizing that under the rubric ‘‘Aging
Research,’’ misled policy makers have
appropriated most available funds to
research on age-associated diseases. Yet
no advance in geriatric medicine will
add to our knowledge of the
fundamental biology of aging [1–3]. &
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